Get startedLog in
    Picture of Mithra Pharmaceuticals SA logo

    MITRA — Mithra Pharmaceuticals SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: Mithra's Nextstellis® Granted Additional Patent In United States

    Picture of Mithra Pharmaceuticals SA logoMithra Pharmaceuticals SA
    07/11/2023 06:13
    Nov 7 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * MITHRA'S NEXTSTELLIS® GRANTED ADDITIONAL PATENT IN UNITED
STATES
    * NEW PATENT EXTENDS PROTECTION FOR NEXTSTELLIS® (ESTELLE®)
UNTIL
2036
    * MAYNE PHARMA HAS A 20-YEAR EXCLUSIVE LICENSE AND SUPPLY
AGREEMENT IN US AND AUSTRALIA FOR NEXTSTELLIS®

Source text for Eikon:  ID:nGNE2ngjHk 
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Mithra Pharmaceuticals SA

    See all news